Our newly created ATIP-Avenir group is looking for a post-doctoral fellow, to be funded for up to two years. The group focuses on cancer epigenomics with the aim to understand the role of epigenetic changes in cancer development and progression and associate these changes with genetics modifications. Currently the group works with neuroblastoma and adrenocortical carcinomas.
The post-doctoral project will involve analysis of histone modifications profiles in neuroblastoma and adrenocortical carcinoma primary tumors coupled with the analysis of genetic events (mutations and amplifications in cancer pathways). Depending on the candidate’s background and experience, this project may involve development of computational methodology, data mining and wet lab experiments to validate computational results or work on drug sensitivity. This project will implicate production and analysis of several types of high-throughput data including targeted sequencing, ChIP-seq, ATAC-seq and RNA-seq data. The candidate will interact with top leading groups in cancer biology that are parts of the laboratory of endocrine tumors and signaling of Institut Cochin and the laboratory of genetics and biology of cancers of Institut Curie. In summary, we offer an opportunity to work on a complex biological question with the application of high-throughput data that has direct implications in the research against cancer.
Starting date: January 1, 2016 or later